 Antidepressive Agents
"Antidepressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
| Descriptor ID |
D000928
|
| MeSH Number(s) |
D27.505.954.427.700.122
|
| Concept/Terms |
Antidepressive Agents- Antidepressive Agents
- Agents, Antidepressive
- Antidepressant Drugs
- Drugs, Antidepressant
- Antidepressants
|
Below are MeSH descriptors whose meaning is more general than "Antidepressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antidepressive Agents".
This graph shows the total number of publications written about "Antidepressive Agents" by people in this website by year, and whether "Antidepressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1995 | 0 | 1 | 1 | | 1996 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1999 | 1 | 2 | 3 | | 2001 | 0 | 1 | 1 | | 2002 | 1 | 0 | 1 | | 2004 | 2 | 0 | 2 | | 2005 | 4 | 4 | 8 | | 2006 | 2 | 2 | 4 | | 2007 | 5 | 0 | 5 | | 2008 | 3 | 7 | 10 | | 2009 | 5 | 2 | 7 | | 2010 | 5 | 1 | 6 | | 2011 | 8 | 2 | 10 | | 2012 | 9 | 8 | 17 | | 2013 | 7 | 5 | 12 | | 2014 | 8 | 1 | 9 | | 2015 | 6 | 1 | 7 | | 2016 | 6 | 5 | 11 | | 2017 | 7 | 0 | 7 | | 2018 | 5 | 4 | 9 | | 2019 | 3 | 4 | 7 | | 2020 | 1 | 2 | 3 | | 2021 | 3 | 1 | 4 | | 2022 | 1 | 3 | 4 | | 2023 | 1 | 4 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Antidepressive Agents" by people in Profiles.
-
Hoffman GR, Olson MG, Schoffstall AM, Est?vez RF, Van den Eynde V, Gillman PK, Stabio ME. Classics in Chemical Neuroscience: Selegiline, Isocarboxazid, Phenelzine, and Tranylcypromine. ACS Chem Neurosci. 2023 12 06; 14(23):4064-4075.
-
Tyler MP, Wright BJ, Beaton R, Monger K, Raison CL, Lowry CA, Evans L, Hale MW. Severity of depressive symptoms moderates the sympathoinhibitory effect of local skin warming following exposure to a social stressor. Psychoneuroendocrinology. 2024 Jan; 159:106420.
-
Lavigne JE, Hur K, Gibbons JB, Pigeon WR. Associations between insomnia medications and risk of death by suicide. Sleep Med. 2023 11; 111:199-206.
-
Freedman R. Ketamine and ECT in Depression - Risks and Rewards. N Engl J Med. 2023 Jun 22; 388(25):2389-2390.
-
Flux MC, Smith DG, Allen JJB, Mehl MR, Medrano A, Begay TK, Middlemist BH, Marquart BM, Cole SP, Sauder CJ, Lowry CA, Raison CL. Association of plasma cytokines and antidepressant response following mild-intensity whole-body hyperthermia in major depressive disorder. Transl Psychiatry. 2023 04 21; 13(1):132.
-
Zimbrean PC, Andrews SR, Hussain F, Fireman M, Kuntz K, Niazi SK, Simpson SA, Soeprono T, Winder GS, Jowsey-Gregoire SG. ACLP Best Practice Guidance: Evaluation and Treatment of Depression in Solid Organ Transplant Recipients. J Acad Consult Liaison Psychiatry. 2023 Jul-Aug; 64(4):357-370.
-
Zanos P, Brown KA, Georgiou P, Yuan P, Zarate CA, Thompson SM, Gould TD. NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine. J Neurosci. 2023 02 08; 43(6):1038-1050.
-
Thompson SM. Plasticity of synapses and reward circuit function in the genesis and treatment of depression. Neuropsychopharmacology. 2023 01; 48(1):90-103.
-
Georgiou P, Zanos P, Mou TM, An X, Gerhard DM, Dryanovski DI, Potter LE, Highland JN, Jenne CE, Stewart BW, Pultorak KJ, Yuan P, Powels CF, Lovett J, Pereira EFR, Clark SM, Tonelli LH, Moaddel R, Zarate CA, Duman RS, Thompson SM, Gould TD. Experimenters' sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor. Nat Neurosci. 2022 09; 25(9):1191-1200.
-
Ogilvie AC, Carnahan RM, Chrischilles EA, Schultz JL. The effects of antidepressants on depressive symptoms in manifest Huntington's disease. J Psychosom Res. 2022 11; 162:111023.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|